Anti-virals
Showing 1 - 25 of >10,000
SARS-CoV-2 Infection, COVID-19 Trial in Derby (Remdesivir)
Not yet recruiting
- SARS-CoV-2 Infection
- COVID-19
-
Derby, United KingdomUniversity of Derby
Jun 21, 2023
COVID-19 Pneumonia, Covid19, COVID-19 Acute Respiratory Distress Syndrome Trial in Mansoura (Sodium Bicarbonate Solution,
Active, not recruiting
- COVID-19 Pneumonia
- +2 more
- Sodium Bicarbonate Solution
- Placebo
-
Mansoura, DK, EgyptMansoura University Hospital - Chest Departement
Sep 2, 2021
Kidney Transplant, Hepatitis C Trial in Richmond (Direct acting Anti-Viral Therapy using Epclusa or Zepatier)
Completed
- Kidney Transplant
- Hepatitis C
- Direct acting Anti-Viral Therapy using Epclusa or Zepatier
-
Richmond, VirginiaVirginia Commonwealth University
Mar 26, 2020
Diagnostic Score for Encephalitis to Assess Risk of Autoimmune
Recruiting
- Autoimmune Encephalitis
- Autoimmune Encephalitis Caused by N-Methyl D-Aspartate Receptor Antibody (Disorder)
- Clinical score of Granillo and al.
-
Lyon, FranceCentre de référence des syndromes neurologiques paranéoplasiques
Jul 12, 2023
Thromboprophylactic Dosage Nadroparin in Critically Ill COVID-19
Completed
- Critical Illness
- +2 more
- blood sampling
-
Arnhem, NetherlandsMonique de Maat
Jun 28, 2023
Technology Trial in Hong Kong (The anti-wandering system)
Not yet recruiting
- Technology
- The anti-wandering system
-
Hong Kong, Hong KongHaven of Hope Residential Service for the Disabled
Mar 28, 2023
NSCLC Trial in Beijing, Tianjin (TQB2450 injection, docetaxel injection matching , AL2846 capsules, TQB2450 matching , docetaxel
Recruiting
- Non-small Cell Lung Cancer
- TQB2450 injection, docetaxel injection matching placebo, AL2846 capsules
- TQB2450 matching placebo, docetaxel injection, AL2846 matching placebo
-
Beijing, Beijing, China
- +2 more
Jun 19, 2023
Seasonal Allergic Rhinitis Trial in China (LP-003 dose 1, LP-003 dose 2, Placebo)
Recruiting
- Seasonal Allergic Rhinitis
- LP-003 dose 1
- +2 more
-
Beijing, Beijing, China
- +16 more
Sep 18, 2023
Celiac Disease Trial in Spain
Recruiting
- Celiac Disease
-
Terrassa, Barcelona, Spain
- +5 more
Aug 10, 2023
Thyroid Diseases, Hypothyroidism, Hashimoto Disease Trial in Tehran (curcumin, Anti-inflammatory diet)
Not yet recruiting
- Thyroid Diseases
- +2 more
- curcumin
- Anti-inflammatory diet
-
Tehran, National Nutrition And Food Technology Research Institute, Iran, Islamic Republic ofGolbon Sohrab
Jul 27, 2023
Post-endodontic Pain Trial in Cairo (Cryotherapy, Diclofenac sodium, Dexamethasone sodium phosphate)
Recruiting
- Post-endodontic Pain
- Cryotherapy
- +2 more
-
Cairo, EgyptAin Shams University
Oct 13, 2023
T- and B-Cell Subpopulations in Membranous Nephropathy
Recruiting
- Membranous Nephropathy
- +2 more
-
Istanbul, TurkeyIstanbul University
May 31, 2023
Unresectable Clinical Stage III Merkel Cell Carcinoma AJCC v8, Clinical Stage IV Merkel Cell Carcinoma AJCC v8, Merkel Cell
Not yet recruiting
- Unresectable Clinical Stage III Merkel Cell Carcinoma AJCC v8
- +2 more
- Biopsy
- +6 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Sep 28, 2023
Refractory Cancer, Recurrent Cancer, Solid Tumor, Adult Trial in Germany (IMA402 (Phase Ia), IMA402 (Phase Ib), IMA402 (Phase
Not yet recruiting
- Refractory Cancer
- +3 more
- IMA402 (Phase Ia)
- +2 more
-
Heidelberg, Baden-Wuerttemberg, Germany
- +12 more
Jul 14, 2023
HER2-positive Gastric Cancer, Immunotherapy Trial in Shanghai (Disitamab Vedotin combined with fruquintinib and Tislelizumab)
Recruiting
- HER2-positive Gastric Cancer
- Immunotherapy
- Disitamab Vedotin combined with fruquintinib and Tislelizumab
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
Aug 8, 2023
Locally Advanced Rectal Cancer Trial in Guangzhou (AK104, Capecitabine, Neoadjuvant Radiotherapy)
Not yet recruiting
- Locally Advanced Rectal Cancer
- AK104
- +2 more
-
Guangzhou, Guangdong, ChinaSun Yat-sen University Cancer Center
Aug 5, 2023
Wrinkle, Spot Pigmented, Lines Skin Trial in Clearwater (Nutraceutical Topical)
Recruiting
- Wrinkle
- +2 more
- Nutraceutical Topical
-
Clearwater, FloridaLaser Scalp and Hair Center
Feb 9, 2023
Ulcerative Colitis Trial ("Mesalamine" and "alpha-lipoic acid", "Mesalamine" and "Placebo")
Not yet recruiting
- Ulcerative Colitis
- "Mesalamine" and "alpha-lipoic acid"
- "Mesalamine" and "Placebo"
- (no location specified)
Oct 5, 2023
Focal Laser Single Intravitreal Ranibizumab Retinal Artery
Completed
- Retinal Artery Macroaneurysm
- Dual focal laser and intravitreal Ranibizumab injection
-
Cairo, EgyptKasr alainy faculty of medicine
Jan 29, 2023
Muscle-Invasive Bladder Carcinoma, Programmed Cell Death Protein 1 Inhibitor, Radiotherapy Trial in Guangzhou (Toripalimab,
Not yet recruiting
- Muscle-Invasive Bladder Carcinoma
- +2 more
- Toripalimab
- +4 more
-
Guangzhou, Guangdong, ChinaCancer Center, Sun Yat-sen University
Aug 3, 2023
Macular Edema Due to Type 2 Diabetes Trial in Hangzhou (Anti-VEGF, subthreshold micropulse laser)
Recruiting
- Macular Edema Due to Type 2 Diabetes Mellitus
- Anti-VEGF
- subthreshold micropulse laser
-
Hangzhou, Zhejiang, ChinaSecond Affiliated Hospital, School of Medicine, Zhejiang Univers
Feb 26, 2023
Metabolic Syndrome Trial in Arifwala (Black Mulberry Fruit Powder)
Not yet recruiting
- Metabolic Syndrome
- Black Mulberry Fruit Powder
-
Arifwala, Punjab, PakistanTHQ Hospital
Jul 13, 2023
Wrinkle, Skin Laxity, Skin Manifestations Trial in Shanghai (Fotona4D Pro® treatment followed by daily use of formulations
Active, not recruiting
- Wrinkle
- +3 more
- Fotona4D Pro® treatment followed by daily use of formulations containing MLYAAT-1002®
- Fotona4D Pro® treatment followed by daily use of formulations without MLYAAT-1002®
-
Shanghai, Shanghai, ChinaShanghai China-norm Quality Technical Service Co., Ltd.
Nov 19, 2023
Determination of Blood Tumor Cells
Completed
- Leukemia, Lymphocytic, Chronic, B-Cell
- Abnormalities Cell Epithelial
-
Zurich, SwitzerlandUniversity Hospital Zurich
Jan 9, 2023